COV — Toxotis Investments Public Balance Sheet
0.000.00%
Last trade - 00:00FinancialsMicro Cap
Annual balance sheet for Toxotis Investments Public, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Interim Report | ARS | ARS | ARS |
| Standards: | IFRS | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.788 | 0.818 | 0.806 | 0.578 | 0.62 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.059 | 0.536 | 0.538 | 0.532 | 1.65 |
| Total Current Assets | 0.846 | 1.35 | 1.34 | 1.11 | 2.27 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 3.4 | 3.77 | 3.84 | 5.39 | 5.12 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 2.63 | 3.43 | 3.66 | 5.45 | 4.33 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.8 | 3.58 | 3.81 | 5.61 | 5.99 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 0.598 | 0.189 | 0.038 | -0.225 | -0.867 |
| Total Liabilities & Shareholders' Equity | 3.4 | 3.77 | 3.84 | 5.39 | 5.12 |
| Total Common Shares Outstanding |